Prothymosin α1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro

This publication has 23 references indexed in Scilit:

• Thymosin α1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: Preliminary results
  International Journal of Immunopharmacology, 1994
• Prothymosin α receptors on peripheral blood mononuclear cells
  FEBS Letters, 1994
• Prognostic value of non-MHC-restricted killer cell activity in lung cancer
  Cancer Immunology, Immunotherapy, 1993
• Interleukin-2 bolus therapy induces immediate and selective disappearance from peripheral blood of all lymphocyte subpopulations displaying natural killer activity: Role of cell adhesion to endothelium
  European Journal Of Cancer, 1992
• Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytes
  International Journal of Immunopharmacology, 1991
• Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma
  British Journal of Dermatology, 1991
• Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes
  International Journal of Immunopharmacology, 1990
• Synergistic effect of thymosin α1 and αβ-interferon on NK activity in tumor-bearing mice
  International Journal of Immunopharmacology, 1989
• Characterization of the immunoregulatory properties of thymosin alpha 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes
  International Journal of Immunopharmacology, 1989
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987